Lisa F. Pratt 1, Matthew Troese 1, Dirk Weisensee 2, Oliver Engelking 2, Horst W. Fuchs 2 and George DeGeorge 1

Similar documents
Matthew Troese 1, Bennett Varsho 1, Dirk Weisensee 2 and George DeGeorge 1

PRESENTATION LAYOUT Introduction to chemical allergy. In vivo models. In vitro models

Micheal Carathers, Bennett Varsho, Puneet Vij, and George DeGeorge

Background on skin sensitization hazard identification: Aspects in the development of «in-vitro based alternatives for sensitization testing»

MB Research Labs. Local Lymph Node Assay using Flow Cytometric Endpoints. An Alternative to the Radioactive LLNA. Experience and Innovation

VITOSENS, Gene expression in denritic cells

Skin sensitization non-animal risk assessment Determination of a NESIL for use in risk assessment

Toxicogenomic Investigation into False Positive Responses in the Local Lymph Node Assay (LLNA)

Assessment of the in vitro skin irritation of chemicals using the Vitrolife-Skin human skin model

Toxicology Letters 192 (2010) Contents lists available at ScienceDirect. Toxicology Letters. journal homepage:

Manuscript Draft. Keywords: Local lymph node assay, LLNA: BrdU-FCM, Skin sensitization, BALB/c, CBA/J, Flow cytometry

Sensitization testing in the frame of REACH: Any reliable in vitro alternatives in sight?

OECD GUIDELINE FOR THE TESTING OF CHEMICALS

Local Lymph Node Assay: 5-bromo-2-deoxyuridine-flow cytometry method (LLNA: BrdU-FCM) Validation Study Report

Potency classification of skin sensitizers (EC WG on Sensitization)

Table of Validated and Accepted Alternative Methods

HOW GOOD ARE VALIDATED METHODS TO PREDICT TOXICITY OF DIFFERENT TYPES OF SUBSTANCES AND PRODUCTS?

FROM PATHWAYS TO PEOPLE: APPLYING THE SKIN SENSITISATION AOP TO RISK ASSESSMENT

Regulatory need for non-animal approaches for skin sensitisation hazard assessment. Janine Ezendam

What differentiates respiratory sensitizers from skin sensitizers?

Local Lymph Node Assay: 5-bromo-2-deoxyuridine-flow cytometry method (LLNA: BrdU-FCM) Validation Study Report

Use of a B Cell Marker (B220) to Discriminate between Allergens and Irritants in the Local Lymph Node Assay

NIH Public Access Author Manuscript J Invest Dermatol. Author manuscript; available in PMC 2014 April 01.

Application of the KeratinoSens Assay for Prediction of Dermal Sensitization Hazard for Botanical Cosmetic Ingredients

OECD GUIDELINE FOR THE TESTING OF CHEMICALS

Use of the Caenorhabditis elegans as an alternative model for evaluating the allergen potential of skin sensitizers

Assessment of the in vitro skin irritaion by chemicals using the Vitrolife-Skin human skin model

Innovative. Quantitative. Recognized.

Why me? 35 years in toxicology, incl. 28 with Unilever. Director of DABMEB Consultancy Ltd for 6 years

Methyldibromoglutaronitrile

Potency Values from the Local Lymph Node Assay: Application to Classification, Labelling and Risk Assessment. Document No. 46

Toxicology Letters 209 (2012) Contents lists available at SciVerse ScienceDirect. Toxicology Letters

Annex II: Lymph node assay (LLNA) data on 59 fragrance substances, based on a summary report submitted by the Research Institute for Fragrance

Sherlock Holmes goesmolecular: Allergische Kontaktdermatitis von PatchTest zu Prohaptenen(I)

Sens-it-iv Proof-of-concept studies

CASE STUDY PRESENTATION: A QUANTITATIVE AOP FOR SKIN SENSITISATION RISK ASSESSMENT

Multivariate Models for Skin Sensitization Hazard and Potency

Evaluation of Sex Sensitivity in Local Lymph Node Assay Using Acephate and α- Hexylcinnamaldehyde

Assessing the sensitization/irritation properties of micro organisms. Gregorio Loprieno Prevention Medicine Local Health Authority 2 Lucca (Italy)

Pre & Pro Haptens in Fragrance: Part 2 - Hydrolysis

A chemical dataset for evaluation of alternative approaches to skin-sensitization testing

Public Assessment Report for a Homeopathic Medicinal Product for Human Use

Skin Exposure to Weak and Moderate Contact Allergens Induces IFNc Production by Lymph Node Cells of CD4 þ T-Cell-Depleted Mice

SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS SCCP. Memorandum Classification and categorization of skin sensitisers and grading of test reactions

An Example of Cross-Sector Dialogue at a Global Scale: The Case of Skin Sensitization

LRI Workshop: Applicability of Skin Sensitisation Testing Methods for Regulatory Purposes. Brussels; 2-3 February 2010

Contact Sensitisation: Classification According to Potency A Commentary. Document No. 43

FORUM Skin Sensitization Testing in Potency and Risk Assessment

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCCP

Identification of substances as SVHCs due to equivalent level of concern to CMRs (Article 57(f)) sensitisers as an example

In vitro models for assessment of the respiratory sensitization potential of compounds.

Dermal Sensitization Quantitative Risk Assessment (QRA) For Fragrance Ingredients

Public Assessment Report for a Homeopathic Medicinal Product for Human Use

Ancient Wisdom. Contains CAS/EINECS Hazard Symbols Conc%

Occupational skin diseases (OSD): current research and prevention activities in Europe

Application of the calculation method in regulatory risk assessment. Part 1 The issue of animal studies

OPINION ON. Oak moss / Tree moss

Critical Comment. Evaluation of. selected sensitizing. fragrance. substances

Contact Sensitisation: Classification According to Potency. Technical Report No. 87

Prof. Jean-Pierre Lepoittevin University of Strasbourg, France SCCS WG on methodology Luxemburg, July 1st 2015

Material Safety Data Sheet

Ward/Unit/Team managers to carry out an occupational skin disease risk assessment for their area

An In Vitro Assay to Screen for the Sensitizing Potential of Xenobiotics

Version 5 (October 2013)

OPINION ON. 2-Methoxy-methyl-p-phenylenediamine and its sulfate salt

OECD GUIDELINE FOR THE TESTING OF CHEMICALS

TARGETED RISK ASSESSMENT REPORT ON SODIUM HYDROXIDE (NAOH) HUMAN HEALTH PART. CAS No.: ; EINECS No.:

Ancient Wisdom. Contains CAS/EINECS Hazard Symbols Conc%

Progress towards novel. for. assessment of allergens. Erwin L Roggen, Hans-Ulrich Weltzien, Helma Hermans. The Sens-it-iv Consortium

SAFETY DATA SHEET according to Regulation (EU) 2015/830

Challenges of 21 st Century Toxicology

Technical Report No. 78. Skin Sensitisation Testing: Methodological Considerations

In Vitro Lecture and Luncheon. Sponsored by the Colgate Palmolive Company

It s all in your hands: Preventing hand dermatitis. Introduction 3/5/2018. Hand hygiene is a cornerstone of effective infection control, but

Eczema & Dermatitis Clinical features: Histopathological features: Classification:

IR3535, the nature inspired repellent from Merck

Internal Use The form of MSM available for internal use is powder or crystalline, but can be mixed in food or beverages if you prefer.

Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells

Report /2009 J. Ezendam et al. Immune effects of inhalation exposure to fragrance allergens

EU Safety Data Sheet. Enzyme Conjugate. 1 Identification of the substance/mixture and of the company

Technical Datasheet LIFTONIN -XPRESS. 1. Application and Storage. Page 1 of 6. Country of Origin. Nature of Raw Materials

MATERIAL SAFETY DATA SHEET according to Regulation (EC) No 1907/2006 (REACH),

Annex III: Tabular summary of dose-elicitation studies in sensitised patients

Revision of GHS Chapter 3.2 to fully incorporate non-animal test methods

Material Safety Data Sheet

Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects

World Leather Congress 2015 Milan, Italy, September 8, Chromium in leather: is it a real health problem? Angelo Moretto

EFSA GD on dermal absorption Industry feedback and considerations on bridging opportunities

MATERIAL SAFETY DATA SHEET according to Regulation (EC) No 1907/2006 (REACH),

François M.M. van Och, Wout Slob, Wim H. de Jong, Rob J. Vandebriel, Henk van Loveren *

Ingredient Product Information File FARMAL CS 3757

Safety Data Sheet. according to Regulation (EC) No. 1907/2006. Nelkenöl (Eugenol) Print date: Page 1 of 6

NOPALEX BARNET. Multi tested anti inflammatory acting

Is Rosin Classifiable as a Skin Sensitiser? Paul Illing

MATERIAL SAFETY DATA SHEET (MSDS)/SAFETY DATA SHEET (SDS) Equine Profile Plus

NEXT GENERATION RISK ASSESSMENT FOR CONSUMER SAFETY OF COSMETICS: A CASE STUDY APPROACH

MATERIAL SAFETY DATA SHEET (MSDS)/SAFETY DATA SHEET (SDS)

Topical nanocrystalline silver cream inhibits expression of matrix metalloproteinase-9 in animal models of allergic contact dermatitis.

Transcription:

Potency Ranking of Dermal Sensitizing Chemicals Using the IVSA and epics Skin Tissues Lisa F. Pratt, Matthew Troese, Dirk Weisensee 2, Oliver Engelking 2, Horst W. Fuchs 2 and George DeGeorge MB Research Laboratories, Spinnerstown, PA, USA 2 CellSystems Biotechnologie Vertrieb GmbH, Troisdorf, Germany ABSTRACT Human 3D reconstructed skin epidermal equivalents have been shown to release IL-8 in response to a wide range of dermal sensitizing chemicals. The concentration of these chemicals that produce greater than a threshold positive response (Stimulation Index, SI 2.) is correlated to their potency or strength in an In Vitro Sensitization Assay (IVSA). In our experiments, 4-Nitrobenzyl bromide (NBB) and 2,4-Dinitrochlorobenzene (DNCB) were strong inducers of IL-8 secretion into the culture medium (SI-2 =. and.3%, respectively). The strong sensitizer p-phenylenediamine (PPD) had an SI-2 of.3%. Cinnamaldehyde (CA) (SI-2 =.33%) and Isoeugenol (IE) (SI-2 =.56%) were moderate sensitizers, while Eugenol (EU) (SI-2 =.75), Resorcinol (RES) (SI-2 = 2.9%) and Hexylcinnamaldehyde (HCA) (SI-2 = 8.8%) were weak sensitizers. Sensitizer potency ranked using an SI-2 as follows: NBB > DNCB > PPD > CA > IE > EU > RES > HCA, with NBB, DNCB and PPD classified as strong, CA, IE and EU as moderate, and RES and HCA classified as weak sensitizers. Of the total of 8 chemicals tested, seven were irritants and two were non-sensitizers (Glycerol and Isopropanol); of these, only Chlorobenzene (5%) was incorrectly predicted as a sensitizer. epics gave an Accuracy of 89% and Sensitivity of 89%, and all other Cooper Statistics (Specificity, Negative and Positive Predictivity) values were 89%. In summary, measuring IL-8 release from 3D tissues allows for highly accurate and sensitive identification of dermal sensitizers. Also, the ability to rank-order potency of these chemicals based on SI-2. values of IL-8 secretion is a powerful tool for further classification into potency categories. MB Research Labs +-25-536-4 clientservices@mbresearch.com

CellSystems Biotechnologie Vertrieb GmbH INTRODUCTION The CDC estimates more than 3 million individuals in the US are likely exposed to chemicals that cause skin diseases. Many of these skin diseases are caused by contact dermatitis, a common type of illness associated with many occupational hazards, costing an estimated one billion dollars annually in healthcare and lost productivity (http://www.cdc.gov/niosh/topics/skin/). Currently there are no fully validated and regulatory accepted animal-alternative methods available to assess for Allergic Contact Dermatitis (ACD) / sensitization. In ACD, keratinocytes in the skin are the first to contact and elicit a response to allergens during an exposure. The 3D human epidermis equivalent epics is reconstructed from normal human primary epidermal keratinocytes. Keratinocytes have been shown to secrete a wide range of cytokines. Evidence demonstrates that cytokine IL-8 is an essential component of dermal sensitization. Most notable it has been shown using IL-8-deficient mice that IL-8 is not required for irritation contact dermatitis, but is required for an optimal ACD response (Antonopoulos et al., 28. Journal of Leukocyte Biology 83: 36-7). An IL-8 endpoint has been used to predict sensitization in tissue models using filter paper applications (Gibbs et al., 23, Toxicology and Applied Pharmacology 272(2):529-4). To identify sensitizing compounds, we measured IL-8 secretion from epics after treatment with pure chemicals via direct chemical application. MATERIALS AND METHODS Sensitizers and irritants/non-sensitizers were topically applied directly to the stratum corneum of epics tissues. The primary vehicles used were Ethanol and Acetone:Olive Oil (AOO). At 24 hours post-chemical application, media was sampled and analyzed by ELISA (MBL, Nagano, Japan) for secreted IL-8. IL-8 responses were measured as a Stimulation Index (SI), a fold increase above vehicle control. Tissues were washed and then tissue viability was measured by the MTT assay. The chemical concentration that results in 5% loss in tissue viability (TV5) was calculated when possible. At least two independent experiments were performed for each chemical. An SI of 2. was chosen as a cut-off for a positive response. A material was considered positive if at least one concentration of the material tested positive in at least two independent experiments. RESULTS Table. Contingency Table (SI=2 of IL-8) Known + Known Total Tested + 8 9 Tested 8 9 Total 9 9 8 Accuracy 89% (6/8) Sensitivity 89% (8/9) Specificity 89% (8/9) Positive Predictivity 89% (8/9) Negative Predictivity 89% (8/9) MB Research Labs +-25-536-4 clientservices@mbresearch.com 2

CellSystems Biotechnologie Vertrieb GmbH Table 2. Chemicals Tested in epics IVSA Chemicals IL-8 a Result SI-2 b % TV5 c LLNAd EC3 % Human e DSA 5 (μg/cm 2 ) Sensitizer * 4-Nitrobenzylbromide (NBB) +.2.4.5 2 -Chloro-2,4-Dinitrobenzene (DNCB) +.3.5.3 3.8 3 p-phenylenediamine (PPD) +.3.67.3 76 4 Cinnamaldehyde +.33.48.7 634 5 IsoEugenol +.56.78.7,54 6 Eugenol +.75.9.73 5,926 7 Resorcinol + 2.9 2.82 5.5 8 α-hca + 8.8 2.9 9.37 23,622 Cinnamyl Alcohol (Cinn-OH) na.4 2. 3,747 Irritants Lactic Acid na 3. na na Phenol na 2.22 na na Sodium Dodecyl Sulfate (SDS) na na na Methyl Salicylate na 3.6 na na Chlorobenzene + na 6.4 na na Salicylic Acid na 2.5 na na Tween 2 na na na Non-Toxic Glycerol na na na Isopropanol na na na a Using a SI-2 as the cutoff for a positive response with IL-8 in epics tissues b The chemical concentration (%) that achieved an SI-2 with IL-8 in epics tissues c The chemical concentration (%) that achieved 5% loss is tissue viability (TV5) in epics d LLNA EC3(%) e Human DSA 5 (μg/cm 2 ) data as reported in Gibbs et al., 23, Toxicology and Applied Pharmacology 272(2):529-4 na = not applicable *see Figure Figure. Correlation of TV5 (EC5) and IL-8 SI-2 SI-2 (IL-8) R² =.94.. 2 4 7 8 6 5 3.. TV5 Concentration (%) MB Research Labs +-25-536-4 clientservices@mbresearch.com 3

Figure 2a. Irritants in the IVSA Stimulation Index (Fold vs. Veh Control) SI Viability 8 6 4 2 % 4% % 4%.5% % 2.5% 5% % 2.5% 25% 5% 2.5% 5% % 25% 5% 75% % % Gly Isopro Lactic Acid Phenol SDS Methyl Salicylate Chlorobenzene Salicyclic Acid Tween -2 cerol. panol. 8 6 4 2 Viability (%) Figure 2a. Sensitizers in the IVSA Stimulation Index (Fold vs. Veh Control) 4 3 2.25%.5%.%.375%.75%.5%.25%.5% %..4%.8%.5% % 5% % 25% 4% 8%.5% % % SI Viability 4% 8 6 4 2 Viability (%) NBB DNCB PPD Cinnamaldehyde IsoEugenol HCA Resorcinol Eugenol Cinnamyl Alcohol MB Research Labs +-25-536-4 clientservices@mbresearch.com 4

Figure 3. IVSA TV5 and IL-8 SI-2 data correlate with Murine LLNA EC3 and Human DSA 5 data TV5 vs. LLNA TV5 vs. Human Skin TV5 Conc. (%). R² =.8 TV5 Conc. (%). R² =.88... LLNA EC3 Concentration (%). Human DSA5 (μg/cm2) SI-2 vs. LLNA Si-2 vs. Human Skin SI-2 (%) R² =.8 SI-2 (%) R² =.96..... LLNA EC3 Concentration (%). Human DSA5 (μg/cm2) CONCLUSIONS An SI of 2. was calculated to be the best fit cut-off to discriminate sensitizers from irritants and non-toxic chemicals. epics IVSA correctly predicted sensitization potential with 89% Accuracy and 89% Sensitivity (8 chemicals). TV5 and IL-8 SI-2 data obtained from epics tissues had very a high correlation (r 2 =.94). Using an SI-2 in this IVSA, data correlated better with Human DSA 5 data (r 2 =.96) than with LLNA EC3 data (r 2 =.8). MB Research Labs +-25-536-4 clientservices@mbresearch.com 5